November 29, 2021
Online Livestream
Medical AffairsLeadership Forum
Digital Strategy and Innovation

DGE’s 5th Digital Strategy & Innovation for Medical Affairs Summit is the largest and most impactful industry event for transforming your medical affairs department into one that implements progressive policies and patient centricity.

As both consumers and HCPs try to adapt to life during COVID – while aiming towards a better future – the demand for detailed and accessible scientific information has never been greater. Now more than ever, your medical affairs team must upskill and stay relevant as consumers use new channels to absorb information.

Our program this year helps you pinpoint best practice in demonstrating value to both internal and external stakeholders in a digital era. Join our growing interactive community that focuses on the cultural digital revolution now available to medical affairs teams!

Next-Gen MSL Excellence
MSLs already had uniquely demanding responsibilities for communicating and gathering key information – and that was before lockdowns and hybrid meetings. Throughout the pandemic, MSLs and field medical teams have been challenged to maintain their relationships with KOLs while prioritizing a work-life balance and advancing their careers.

DGE’s 2nd Next-Gen MSL Excellence Summit returns to provide MSLs and field medical professionals with must-have leadership, team-building and communication tools. Join us February 7-8 in Philadelphia for unequaled learning and networking about how to leverage new technologies, discern meaningful insights, improve stakeholder engagement, and prove value to the organization.

Investigator-Initiated Trials
Investigator-Initiated Trials (IITs), also referred to as an investigator-initiated study (IIS) or investigator-initiated research (IIR) are often described as taking a protocol from “bench to bedside.” IITs are vital to developing new treatments and therapies. With the increasing interest in IITs globally, more biopharmaceutical companies are using IITs as a creative and cost-effective way to innovate and further improve patient safety. As organizations work to improve and expand their IIT programs, it is critical to ensure IIT proposals align with corporate objectives and also demonstrate scientific merit.

DGE inaugural Investigator-Initiated Trials Summit provides an unequaled in-depth examination of the tools that are essential for a successful, complaint IIT.

Attendee Profile
This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:
  • Clinical Data
  • Clinical Operations
  • Clinical Projects
  • Patient Solutions
  • Patient Experience
  • Patient Recruitment
  • Remote Monitoring
  • Trial Design
  • Decentralized Trials
  • Clinical Trials
  • Clinical Supply Chain
  • Clinical Trial Supply Management / CTSM
  • Clinical Technology
  • Clinical Research
  • Clinical Sciences / Clinical Scientific Affairs
  • Digital Health
  • Scientific Affairs
  • Clinical Systems
  • Clinical Processes
  • Medical Affairs
  • Medical Advisors
  • Clinical Safety
  • Clinical Regulatory Affairs
  • Operational Strategy
  • Outsourcing
  • R&D
  • Site Solutions
  • Data Manager
  • Chief Technology Officer
  • Chief Digital Officer
  • Digital Strategy
  • Technical Solutions
  • Medical Director
  • Medical Affairs
  • Digital Engagement
  • Quality Planning
  • Information Technology
  • Site Manager
  • Strategy and Innovation
  • Procurement Manager
  • Regulatory Affairs
  • Business Development
  • Clinical Affairs
  • Clinical Development
  • CQA Auditor
  • Clinical Project Scientist
Event Sponsors
New Topics
Featured Speakers Digital Strategy & Innovation
Featured Speakers Next-Gen MSL Excellence
Event Schedule

Creating  connections  with  KOLs  isn’t  always  easy.  In  the  post-COVID  era,  outreach  can  be particularly  difficult.  Although  many  organizations  prefer  face-to-face  meetings,  virtual meetings  are  here  to  stay  and  many  experts  have  developed  a  preference  for  digital interactions. Now is the time to fine-tune your virtual outreach and take advantage of digital tools.

  • Leverage advisory boards to gather insights
  • Look for flexible discussion tools
  • Seek out experienced vendors

Compliance is a big concern among Medical Affairs professionals when it comes to developing and  publishing  scientific  material.  They  need  new  solutions  for  better,  more  streamlined content management.

  • Reimagine traditional publishing and internal collaborations by identifying compliance concerns and defining solutions
  • Increase the visibility and reach of congress presentations and publications
  • Learn  how  to  collaborate  with  marketing  and  other  internal  stakeholders  to  create compliant materials or engage with virtual activities to meet goals

Understanding where other companies are at with digital innovation is vital.  How do their companies compare and what learnings can you implement at your own company?

  • Share  digital strategies that organizations are implementing and how they are becoming more digital
  • Exchange learnings, pitfalls, and best practices
  • Discuss available software and what organizations are using
  • Start from your customer and build outward into your organization
  • Determine what your customers are looking for
  • Explore how to identify a great customer experience

Learn rapid technical solutions to your most important digital strategy challenges, as technology and platform providers demonstrate in detail the latest features that can resolve your pain points.

Digital transformation is about more than just introducing new technologies or digital tools. Transformation requires rethinking old ways of working and adopting new behaviors. Effective change management is essential for implementing new technologies.

  • Discuss  common  challenges  encountered  during  digital  transformation  in  Medical Affairs using real life examples.
  • Share  lessons  learned  and  recommendations  provided  on  how  to  lead  a  successful transformation.

COVID-19 has accelerated digital adoption and reduced Scientific Leaders’ availability prompting new and innovative methods to educate, inform and engage. Being present is not enough, the digital experience needs to be seamless and frictionless through integrated and interoperable omni-channel touchpoints. Join us in our discussion of how to increase your digital footprint and strategically drive value for your scientific leaders.

  • Discuss omnichannel strategy, learnings and best practices that can help shape the life sciences industry
  • Dive into strategies to engage, educate and inform healthcare professionals at the click of a button

Many organizations lack clarity and urgency on digital strategy and struggle to locate, attract and retain the digital leadership they require. As leaders in the sector have demonstrated, a greater dependence on digital technologies and data may benefit pharmaceutical companies in  a  variety  of  ways.  You  can  set  your  company  at  an  advantage  by  bringing  digital  savvy experts on board – but what happens if you’re not a digital expert yourself?

  • Discover what to look for, questions to ask, and how to interview 
  • Find talent that has the skillsets and vision for digital transformation
  • Recruit talent from outside of pharma with more digital experience

As  the  industry  evolves  beyond  the  traditional  organizational  approaches,  how  do  we  keep the  interconnectivity  within  Medical  Affairs  and  with  other  functions  to  drive  towards  a common goal within the business?

  • Establish  a  framework  for  collaboration  between  the  Medical  Affairs  team  and  the rest of the business units
  • Outline best practices when working together internally and externally
The pandemic has significantly impacted Medical Science Liaisons. With vaccines rolling out and travel opening back up, medical affairs leaders are forced to evaluate how these teams should operate in order to bring the best outcomes.
  • Review trends in the evolution of the MSL role across the industry
  • Discuss how to manage change for evolving MSL teams
  • Use data to enhance strategy for the new MSL role
  • Change existing behavior and adapt to new, innovative tools to add value
As businesses grow more digitally focused, with technology more thoroughly shaping the employee experience, leaders encounter new and unpredictable hurdles to their digital transformation efforts. Do you have the skill set necessary to maintain agile and adaptable leadership?
  • Find ways to simply and streamline your digital systems
  • Adopt a digital-first mindset without losing sight of the human experience
  • Define what success looks like in the context of digital transformation
We live in a world where a reader’s attention span is a few seconds and the competition for customer attention is fierce. HCPs are overwhelmed by the sheer noise of it all. It’s essential to cut through the noise and get the attention of your audience.
  • Deliver snackable, bite-sized content
  • Share your content across the multitude of channels and platforms where HCPs are
  • Review real examples of compliant, digestive, and effective content
HCPs are increasingly using social media as a valid and trusted platform for sharing opinions, dispelling misinformation, and furthering their medical knowledge. Many organizations; however, continue to avoid social media platforms due to a lack of knowledge on how to engage effectively in a compliant way. Medical Affairs teams have a great opportunity to become more involved in the scientific exchange that occurs across social media platforms or risk being silenced completely.
  • Learn how to overcome compliance hurdles and engage HCPs successfully on social media
  • Understand the behaviors and preferences of HCPs
  • Collaborate with DOLs to improve the reach and credibility of your messaging on social channels
The pandemic has compelled pharmaceutical companies to change their communication channels like never before. While some businesses were able to rapidly pivot to virtual releases and prevent delays, others were caught off guard and unable to respond as quickly. It is critical to develop the necessary skillset and digital infrastructure to compete in this new environment.
  • Discuss best practices, pitfalls and learnings
  • Highlight digital tools that reduce barriers
The transition to value-based care is heavily dependent on evidence-based medicine, and pharmaceutical organizations play a key role in scientific communication across the healthcare ecosystem. Because they operate in a highly regulated industry, experts need to communicate authentic, validated information. In order to accomplish this, they are increasingly turning to patient-centric analytics.
  • Understand where patients are in the system in order to target scientific and clinical information to the clinicians who matter
  • Identify signals in real-world data and use them to pinpoint the doctors who are having the most impact on disease burden
Patients are constantly evolving so why are we still insisting that they follow the standard protocol for clinical trial participation?
  • Collect raw patient data in real-time with wearable devices
  • Eliminate barriers to entry that patients face such as geography restrictions, time constraints, and financial investment
The most time-consuming and complex aspect of the clinical trial process is patient recruitment and retention. By failing to keep up with how consumers use technology, the industry spends billions of dollars and takes a decade or more to bring new treatments to market. What is your organization doing to effectively recruit and retain patients in a clinical trial?
  • Establish a recruiting strategy that reaches patients on all channels
  • Tap into the network of social media influencers
  • Develop a thorough prescreening questionnaire to recruit high quality patients
  • Discover how people learn in the digital age
  • Discuss current developments in data visualizations tailored to the audience
  • Convey data and pertscientific messages to ensure engaging content for scientific exchange
  • Use analytics to collect metrics, apply learnings and develop tools for cross-functional use

Medical affairs must be able to measure outcomes, determine the value of engagements, and align activities to meet strategic goals. Incorporating AI can smooth out all of these business processes, as it enables new techniques to measure outcomes, enhance decision-making, and uncover previously hidden impact insights.

  • Capture and measure the value of interactions and engagements with KOLs
  • Measure third party behaviors and inputs
  • Develop a dashboard that allows rapid and visual fruition
Some people are natural born leaders, possessing traits such as self-confidence, extroversion, and high emotional intelligence. However, not every person who becomes a leader has these traits and not every person who has these traits becomes a leader. So, what are the key qualities that distinguish great MSL leaders?
  • Identify the skills and attributes of successful medical affairs leaders
  • Leverage the diversity of backgrounds and experiences within your team
  • Share educational resources for MSL leaders and aspiring leaders
Throughout the course of this pandemic, MSLs have shown their value by staying agile in addressing HCP needs and embracing a wider breadth of medical affairs responsibilities. Given the highly competitive MSL market, what can companies do to retain high-performing, talented field medical professionals?
  • Re-strategize ways to keep field teams motivated and engaged with the organization
  • Define career paths and opportunities for advancement to minimize turnover
  • Address latest compensation trends
Career paths for MSLs can sometimes be hard to navigate. Some MSLs feel stuck in their role and believe they may be limited in their options for career advancement unless they are willing to relocate. With more positions available in the field, what can MSLs do to set themselves up for their next role?
  • Define your career objectives and set actionable goals for professional development
  • Select and engage mentors who can help you achieve your goals
  • Position your skills to show value to the organizations
In today’s tight job market, creating genuine relationships with recruiters is more important than ever. Recruiters can provide more than just job opportunities – they can be offer expert advice on the job market, career advancement opportunities and skill building opportunities.
  • Tips to build a strong two-way relationship with a recruiter
  • Understand the capabilities and culture of the agency
  • Foster relationships in the virtual recruiting
Medical Affairs leaders agree that virtual interviews will continue post-pandemic. From testing out technologies in advance to dressing the part, what can MSLs do to make certain they ace their next virtual interview?
  • Set a checklist to ensure preparedness
  • Develop a confident and engaging room presence
  • Treat your interview like a KOL meeting
Since the pandemic, medical affairs leaders have been challenged with finding creative ways to onboard new MSLs and develop comradery in a virtual setting.
  • Create a win-win scenario in onboarding – how to train new hires while developing current team members
  • It takes a village – how to incorporate all members of your field based medical team in the onboarding process
  • Empower teams to build relationships and comradery within the organization
Face-to-face interactions are making a comeback; however, many practitioners may want to continue to engage virtually. MSLs can continue to build upon their virtual meeting skills to ensure that they are having meaningful and impactful conversations.
  • Maintain awareness of your surroundings during virtual engagements
  • Emphasize spatial design and professional presentation during video conference
  • Best practices to maximize the capabilities of your virtual platform
One of the most exciting things about field medical is how the role continues to evolve. As MSLs continue to adapt to new digital technologies and a more hybrid role, there are several best practices that will ensure success. Join our panel of MSLs and medical affairs leaders as they share their tips for success.
  • Address best practices and core competencies in field medical
  • Review global MSL practices for KOL outreach and engagement
  • Explore different field medical roles and their functions
The MSL role is entirely scientific and non-promotional making it difficult for many organizations to evaluate the effectiveness of field medical teams. Companies are starting to move away from standard quantitative metrics, and now rely on holistic approaches for measuring the impact the field medical team.
  • Present the value of an MSL organization to leadership
  • Educate MSLs on the KPIs they will be evaluated on and the importance of each metric
  • Assign a value to virtual engagements
  • Allow MSLs to contribute to defining a strategy that shows their worth
With so much uncertainty surrounding the pandemic, MSLs are challenged with building and maintaining many of their relationships virtually. While MSLs are experts in communicating complex scientific data, many struggle to add their personal touch and keep virtual engagements conversational.
  • Understand the needs of the HCP and what drives their decisions
  • Develop content that is engaging and encourages HCPs to ask questions and provide insights
  • Incorporate empathy and emotional intelligence in each virtual engagement
  • Reshape data into a patient-centric narrative
MSLs have recently taken on a greater role in all stages of a product lifecycle from clinical development to post-launch. Many organizations are also engaging MSLs in project work that aligns with the medical affairs strategy.
  • Understand the diverse projects MSLs are engaged in at different companies
  • Leverage the diversity and field experience of MSLs in strategic organizational projects
  • Best practices and scenarios that inspire brainstorming and spur creative ideas
Access to KOLs and institutions is always a major challenge for MSLs and field medical professionals. In this uncertain environment, MSLs need to identify and build credibility with new KOLs to engage them in robust scientific discussions.
  • Unique ways to connect and solidify relationships with KOLs when there is no pre-existing relationship
  • Develop a methodical approach to territory management
  • Demonstrate impact and prove MSL value beyond the first meeting
The evolution of digital technology fast-forwarded during the pandemic, and many key opinion leaders are increasingly comfortable with digital engagement. As companies implement omni-channel strategies for engagement, MSLs will need to adapt to effectively operate in this new environment.
  • Understand how omni-channel services transform the medical affairs engagement model
  • Embrace AI and other digital advancements to predict the best path to educating HCPs
  • Incorporate technology to optimize the work of field medical teams
As managed care organizations become more interested in the science behind a therapeutic, companies depend on their expert field medical teams to communicate the value proposition of the drug/device to payer groups. These roles may be siloed at some organizations; however, there are significant opportunities for synergy between medical and HEOR teams.
  • Define the subtle nuances between traditional MSLs and MVL/MCLs
  • Understand payer trends and balance messaging to emphasize HEOR data
  • Bridge gaps and establish ongoing relationships with payer organizations
A key metric for most field medical teams is the quantity of KOLs engagements. However, MSLs need to bring back relevant and actionable insights from these meetings to provide value to their organization.
  • Understand the gap between insights and information
  • Review effective insight-gathering methods to optimize MSL performance
  • Interpret and communicate insights to internal stakeholders (commercial, market access, etc.) in a meaningful manner
Despite unprecedented challenges with the pandemic, the FDA did not slow down their efforts in reviewing and approving new therapies. According to the Center for Drug Evaluation and Research (CDER), there were a total of 53 novel drugs approved in 2020, the second highest count in over 20 years. MSLs and medical affairs teams need to appropriately align their resources to prepare for a successful launch.
  • Best practices and tips for success from successful virtual launches
  • Train and build enthusiasm within the team when a live launch meeting is not feasible
  • Define your KOL universe and territory management plan
From trendy Tik-Toks to discussing the latest study on Twitter, nearly two-thirds of HCPs utilize some form of social media for professional reasons. Social media presents an incredible opportunity for MSLs gain insights from traditional KOLs and the newer DOLs.
  • Determine which channels and approaches are most effective in generating insights
  • Review best practices for identifying and engaging with digital opinion leaders
  • Address compliance concerns that arise from social media interactions
Register Now

This window is secured by 256 bit encryption on a PCI compliant network. Click here to view this window in its own page.

Venue Details
Venue Details

A block of rooms has been reserved at a discounted rate for our conference participants. To reserve a room, please visit or call 215-823-6240 and reference the special rate “DGEB.” The discounted reservation rate will be in effect until JANUARY 17, 2022.

DGE is not affiliated with any third-party booking agencies, bureaus or travel companies. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at DGE has not authorized these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through DGE’s reserved guest room block using the details provided.

Subscribe to Conference Updates
Join our e-newsletter list to follow closely all news.
Event Partners
Contact Us